SCHEMBL29835247

SCHEMBL29835247

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 7/20 0.45
▸ NPY1R P25929 5/20 0.45
▸ NPY2R P49146 3/20 0.45
▸ NPY5R Q15761 3/20 0.45
▸ KISS1R Q969F8 9/20 0.44
▸ BACE1 P56817 2/20 0.44
▸ TFPI P10646 1/20 0.44
▸ CTSD P07339 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30924751 0.93 TFPI (0.44) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL29463703 0.91 KISS1R (0.49) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30768183 0.89 BACE1 (0.53) NPY4RNPY1RNPY2RNPY5RBACE1
SCHEMBL30924757 0.88 NPY4R (0.58) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL30924746 0.88 TFPI (0.59) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL29374718 0.88 TFPI (0.44) KISS1RTFPI
SCHEMBL30818414 0.87 TFPI (0.50) KISS1RTFPI
SCHEMBL29379956 0.87 NPY4R (0.52) NPY4RNPY1RNPY2RNPY5RBACE1
SCHEMBL31097675 0.87 NPY4R (0.55) NPY4RNPY1RNPY2RNPY5RKISS1R
SCHEMBL31097729 0.87 NPY4R (0.55) NPY4RNPY1RNPY2RNPY5RKISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313100-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO Pharma, Inc. (US) 2024-02-07 — — EP disclosed
WO-2022204305-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO PHARMA, INC. (US) 2022-09-29 — — WO disclosed
Send feedback